Impact of dose reducing software on patient and staff dose during fluoroscopically guided cardiac procedures

Fluoroscopy is a vital tool for imaging anatomy and equipment during cardiovascular procedures.  Unfortunately, imaging with x-rays may have detrimental effects on the patient and the staff that are inadvertently exposed due to their proximity to the patient.

This research assesses the effectiveness of dose reducing software during fluoroscopically guided cardiac procedures. Dose levels were measured during coronary angiography, percutaneous coronary intervention, implantation of patent foramina ovale, atrial septal defect and atrial appendage closure devices, and insertion of permanent pacemakers.  Patient and staff dose were compared for two rooms fitted with dose reducing software, to a room that did not have the software installed.

This dataset was produced as part of Kelly Wilson-Stewart's PhD, 'Factors which influence occupational radiation head and eye dose to in-room personnel during angiographic procedures'. 

Kelly's Ph.D. project aims to quantify the levels of temple dose to staff during diagnostic and interventional cardiac and endovascular procedures utilising fluoroscopy.  An additional focus will be placed on reporting on factors that may influence occupational dose levels to nurses and other in-room staff.

The following people were involved in the supervision of this project design and manuscript prepration:

Davide Fontanarosa:

School of Clinical Sciences, Queensland University of Technology, 2 George Street, Brisbane, QLD, 4000, Australia
Centre for Biomedical Technologies (CBT), Queensland University of Technology, Brisbane, QLD, 4000, Australia

Jamie V. Trapp:

School of Chemistry and Physics, Queensland University of Technology, 2 George Street, Brisbane, QLD, 4000, Australia

The following person was involved in statistical analysis, data curation and manuscript preparation:

Eva Malacova:

QMIR Berghofer Medical Research Institute, 200 Herston Road, Herston, QLD, 4006, Australia
Centre for Biomedical Technologies (CBT), Queensland University of Technology, Brisbane, QLD, 4000, Australia

The data owner would like to thank her nursing, radiography, and medical colleagues from the cardio-vascular suites at Greenslopes Private Hospital for their contributions towards data collection during this research. The data owner gratefully also acknowledges the support provided by the Australian Commonwealth Government in the form of a research stipend.

X线透视（Fluoroscopy）是心血管介入操作中用于成像解剖结构与设备的关键工具。然而，X线成像会对因靠近患者而意外暴露的患者与医护人员产生有害影响。

本研究评估了X线透视引导下心脏操作中使用的剂量降低软件的有效性。研究人员在冠状动脉造影术、经皮冠状动脉介入治疗、卵圆孔未闭封堵术、房间隔缺损封堵术、心耳封堵装置植入术以及永久起搏器植入术中测量了辐射剂量水平。将两间安装了剂量降低软件的手术室与一间未安装该软件的手术室的患者及医护人员辐射剂量进行了对比。

本数据集源自Kelly Wilson-Stewart的博士研究课题《血管造影操作中室内人员职业性辐射头部与眼部剂量的影响因素》。

Kelly的博士项目旨在量化采用X线透视的诊断性与介入性心脏及血管内操作中医护人员的颞部辐射剂量水平，并额外聚焦于分析可能影响护士及其他室内医护人员职业辐射剂量的相关因素。

以下人员参与了本项目设计与稿件撰写的指导工作：

Davide Fontanarosa：
澳大利亚昆士兰州布里斯班乔治街2号，邮编4000
昆士兰科技大学生物医学技术中心（Centre for Biomedical Technologies, CBT），澳大利亚昆士兰州布里斯班，邮编4000

Jamie V. Trapp：
澳大利亚昆士兰州布里斯班乔治街2号，邮编4000

以下人员参与了统计分析、数据整理与稿件撰写工作：

Eva Malacova：
澳大利亚昆士兰州赫斯顿市Herston Road 200号，邮编4006，QMIR伯格霍弗医学研究所
昆士兰科技大学生物医学技术中心（CBT），澳大利亚昆士兰州布里斯班，邮编4000

本数据集负责人感谢格林斯洛普斯私立医院心血管科室的护理、放射技师及医学同仁为本研究的数据采集工作提供的支持。同时，数据集负责人衷心感谢澳大利亚联邦政府以研究奖学金形式提供的资助。